Resolution Looms in Apple Watch Blood Oxygen Technology Dispute with Masimo
Background of the Dispute
The conflict between Apple and Masimo over blood oxygen technology began when Masimo accused Apple of stealing its patented technology, claiming that the tech giant's actions have hindered their collaboration efforts since 2013. Earlier this year, a ruling mandated that Apple remove the blood oxygen feature from upcoming Apple Watch models in the US. This legal standoff has left both companies at an impasse.
Leadership Change and Potential Impacts
Joe Kiani's recent resignation has introduced Michelle Brennan as Masimo's new CEO, potentially altering the dynamics of this long-standing dispute. Brennan's leadership may foster a more cooperative environment, paving the way for negotiations that could reintroduce the blood oxygen measurement feature to the Apple Watch.
Future of Apple and Masimo's Relationship
- Potential for a licensing agreement without financial exchange.
- Integration of Masimo's hospital technology with the Health app.
- Possible positive ramifications for both companies' product offerings.
This leadership shift may not only resolve legal tensions but also benefit public health by improving access to reliable health monitoring via Apple Watch.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.